Trials / Completed
CompletedNCT01512901
Efficacy and Safety of Betamethasone Microsphere in Patients With Macular Edema Following Branch Retinal Vein Occlusion (HIKARI)
A Randomized, Sham Controlled, Multicenter, Double-Masked, Phase 2/3 Study Assessing Efficacy and Safety of Betamethasone Microsphere in Patients With Macular Edema Following Branch Retinal Vein Occlusion
- Status
- Completed
- Phase
- Phase 2 / Phase 3
- Study type
- Interventional
- Enrollment
- —
- Sponsor
- Santen Pharmaceutical Co., Ltd. · Industry
- Sex
- All
- Age
- 20 Years
- Healthy volunteers
- Not accepted
Summary
This study will evaluate the efficacy and safety of Betamethasone Microsphere (DE-102) for macular edema following branch retinal vein occlusion
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Betamethasone Microsphere (DE-102） Low Dose | |
| DRUG | Betamethasone Microsphere (DE-102） High Dose | |
| DRUG | Sham |
Timeline
- First posted
- 2012-01-19
- Last updated
- 2014-07-21
Locations
2 sites across 2 countries: Japan, South Korea
Source: ClinicalTrials.gov record NCT01512901. Inclusion in this directory is not an endorsement.